New Health Canada License for BÜHLMANN fCAL® turbo

BÜHLMANN fCAL® turbo

Speed, Quality and Flexibility in Calprotectin Quantification

BUHLMANN Diagnostics Corp (BDC), BÜHLMANN Laboratories AG’s North American affiliate is proud to announce that its innovative product, BÜHLMANN fCAL® turbo, has received a Medical Device License from Health Canada and is now commercially available in Canada.  The device was approved as a Class 2 medical device according to the Canadian Medical Device Regulations.  Read More 

Assay Advantages:

  • Random access
  • Fast results: 10 min
  • Flexible: applicable on all major clinical chemistry analyzers

Health Canada License: 96808

BÜHLMANN fCAL® turbo is Research Use Only in the US.

Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedInEmail this to someone